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Non-technical Summary 
Economic research suggests that public research institutions and universities play an 
important role to push the formation of new technology based firms in university-based 
regions. Thus, we observe a significant higher number of new-technology based firms 
close to private and public research institutions. The positive relationship may result from 
the start-up decision of local scientists which are highly embedded in a region’s research 
network. A second argument emphasizes the attractiveness of university-based regions 
for so called non-embedded entrepreneurs. These entrepreneurs have either weaker 
linkages to a region’s research network or existing linkages imply higher transaction costs 
based on spatial distance. Non-embedded entrepreneurs can potentially be attracted by a 
region’s knowledge base to establish a new firm in this region.  
The study provides first empirical evidence of its kind to test whether university-based 
regions succeed in attracting non-embedded entrepreneurs. This question is particularly 
important with respect to the emergence of new industries. Public authorities have only a 
minor time slot to attract mobile founders. We test the attractiveness hypothesis for the 
modern German biotechnology industry. Biotechnology is an excellent example for a new 
knowledge based industry that is characterized by an extensive use of basic science 
knowledge.  
The ZEW-Foundation Panel and a computer-assisted search for relevant strings are used 
to identify biotechnology firms to form the database for the study. We consider 1,886 
entrepreneurs who are acting in 874 newly founded biotech-firms between 1995 and 
2003. We apply a count data model to analyze the relationship between knowledge and 
the number of entrepreneurs of biotech start-up rates on the level of German counties. 
Our empirical analysis allows differences between several knowledge sources groups of 
entrepreneurs.  
Results of our multivariate analysis indicate a high start-up activity in knowledge 
intensive regions. Group differentiation shows that knowledge stock variables matter only 
for academic founders inside as well as outside the region. In contrast, the start-up 
activity of non-academic founders coming from inside or outside the region cannot be 
explained with knowledge intensity of the region. Our empirical results suggest that 
knowledge spillovers really matter for outsiders, but these spillovers only attract founders 
with a high affinity to research. The message for regional policy is clear and evident: 
Efforts to improve regions’ knowledge base and its signalizing really attract mobile 
founders from other regions. 
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Abstract:  The paper tests empirically the role of knowledge stocks to explain the 
regional distribution of Germany’s biotechnology founders. We present an unique 
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the results of our multivariate analysis indicate a high start-up activity in 
knowledge intensive regions. Group differentiation shows that knowledge stock 
variables matter only for academic founders inside as well as outside the region. In 
contrast, the start-up activity of non-academic founders coming from inside or 
outside the region cannot be explained with knowledge intensity of the region. Our 
empirical results suggest that knowledge spillovers matter, but these spillovers only 
attract founders with high affinity to research. 
 
 
Keywords:  Biotechnology, start-ups, economic geography,  intellectual capital, 
count data model 
JEL Classification:  R30, C21, R58, O30 
                                           
∗  Thanks to Thomas K. Bauer, Georg Licht, Christian Rammer and participants of the meetings 
of “Gesellschaft für Regionalforschung” and “Regionalausschuss des Vereins für 
Socialpolitik” in year 2004 for valuable comments and discussion. All remaining errors and 
shortcomings are, of course, the responsibility of the authors alone.  
1 
1 Introduction 
Many empirical studies show that university-based regions realize higher formation 
rates of new technology-based firms (e.g. Bania et al. 1993, Storey and Tether 1996, 
Harhoff 1997, Nerlinger 1998). The positive relationship may result from the start-
up decision of local scientists, which are highly embedded in region’s research 
network. A second argument emphasize the attractiveness of university-based 
regions for non-embedded entrepreneurs. These kind of entrepreneurs have weaker 
linkages to region’s research network or existing linkages imply higher transaction 
costs based on spatial distance. 
The study provides first empirical evidence of its kind to test the relevance of the 
second argument. The question about attracting non-embedded entrepreneurs, 
especially entrepreneurs outside the region, is particular important with respect to 
the emergence of new industries which is characterized by fast growing number of 
start-ups (see Klepper 1996) and regional clustering in first years. In the 
consequence, public authorities have only a minor time slot to attract mobile 
founders. We test the attractiveness hypothesis for the modern German 
biotechnology industry. Biotechnology is an excellent example for a new knowledge 
based industry that is characterized by an extensively use of basic science 
knowledge. This new knowledge tends to be produced in tacit form. Regions 
provided with high level of biotechnology relevant knowledge seem to have best 
chances to attract potential entrepreneurs to establish a biotech-firm in these 
particular regions. This assumption follows from both the tacit knowledge concept 
combined with localized spillover concept. Tacit knowledge is partially rivalrous 
and needs spatial proximity between knowledge creators and its users to 
commercialize new knowledge in new product or process applications.  
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Zucker et al. (1998) developed a sophisticated approach by focusing on star 
scientists which report genetic-sequence discoveries in GenBank1 (1990) since April 
1990. They observe a significant relationship between the number of star scientist at 
public research institutions and the number of start-ups in the same region. The key 
message is that spatial proximity matters. Their study does not answer, however, 
whether spatial proximity matters for both inside as well as outside entrepreneurs. 
Results of some papers emphasize the relevance of outside entrepreneurs. For 
example, Audretsch and Stephan (1996: 647) show that 42 per cent of university-
based founders moved out their region to be involved as shareholder in biotech firms 
outside their region. Egeln et al. (2004: 213) report that the distance between firm 
location and parent institution reaches 50 kilometres and more for one third of 
public research spin-offs. Probably, knowledge-spillover pulls outside entrepreneurs 
to move in the region.  
We apply a count data model to analyze the relationship between knowledge and 
start-up rates on the level of German counties. Our empirical analysis allows to point 
out differences between several knowledge sources for different groups of 
entrepreneurs. Thus, we learn something more about the importance of different 
research institution and regional conditions to attract inside and outside 
entrepreneurs.  
Our paper is organised as follows. In section two we give some background 
information regarding the determinants of start-up activities in the biotechnology 
industry. Database description and some descriptive results concerning regional 
differences in the start-up activity are followed in section three. Section four deals 
with the explanation of observed regional differences of start-up activities. We 
present the econometric approach briefly and emphasize the interpretation of the 
                                           
1 GenBank is an annotated collection of all publicly available DNA sequences  
(http://www.psc.edu/general/software/packages/genbank/genbank.html [26.3.2004]). 
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estimation results in this section. Main results are summarized and concluding 
remarks are given in section five. 
 
2 Conceptual Framework 
New biotech firms are predominantly, independent companies; that is, individuals 
typically have a stake in their foundation. Market entries by established firms are 
less common. These aspects are typical for new, technology-intensive industries’ 
early-phase emergence (cp. Winter 1984, Agarwal and Audretsch 2001). 
Every independent firm foundation in a region is the result of two entrepreneurial 
decisions: first the decision to take over entrepreneurial function (= foundation 
decision) and second the choice of location. Both can occur either simultaneously or 
successively. Further, the availability of suitable locations is presumed to influence 
the foundation decision. The foundation decision is a matter of economical, 
sociological and psychological revision (Pfeiffer 1994, Brüderl et al. 1996, Frick et 
al. 1998), while one can rely on location-related theories of micro- and 
macroeconomic units in explaining theoretical motivations behind the choice of 
location (Marshall 1890, Weber 1909, Böventer 1979, Gehrung 1996). In the 
context of empirical analysis of regional firm distribution in general and of specific 
biotech firm foundations, one can hardly separate the two decisions.  
We assume an utility maximizing person and therefore, a firm is usually founded 
when one’s expected utility by entrepreneurial activity exceeds that of alternative 
occupations. The expected utility depends on distinct variables, such as his or her 
ambitions regarding personal autonomy and income as well as the respective newly 
founded firm’s survival prospects and expected profitability. Both may be affected 
by the material and intangible resources available to the potential founder. These 
resources are then combined in order to realize a competitive advantage; that is, a 
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successful implementation of the respective firm’s founding concepts (Barney 1991, 
Peteraf 1993, Prahalad and Hamel 1990). 
The resource-based view (RBV) emphasizes material, financial and organisational 
resources (Penrose 1959, Wernefelt 1984). In correlation with the increased 
importance of knowledge in certain industries, the knowledge-based view (KBV), an 
independent theoretical path, was developed. This perspective considers the 
localization, generation, utilization, transfer and protection of knowledge to 
comprise the essential foundation of obtaining competitive advantages. With respect 
to biotechnology, Zucker et al. (1994, 1995, 1998) and Audretsch and Stephan 
(1999) go one step further, accentuating the significance of so-called “star 
scientists”. These represent an important stock of knowledge of the modern 
biotechnology and the possible impact of the development of commercial 
applications.  
Knowledge itself can be categorized as explicit or implicit.  In contrast to explicit 
knowledge, which can be documented and easily communicated (Polanyi 1958)2, 
implicit knowledge (also called tacit knowledge) constitutes the undocumented 
knowledge contained within people (Nahapiet and Goshal 1998, Grant 1996, 
Nonaka and Takeuchi 1995). It is typically the founders themselves who possess the 
tacit knowledge of particular technologies, products or procedures that served as the 
foundation of their business ideas. Some of these knowledge resources form an 
important basis for realizing competitive advantages and thus of income 
opportunities; these alone, however, are often insufficient. The capacity to share 
knowledge internally and acquire new knowledge makes a similar contribution. The 
so called “absorptive capacity”, based on a concept developed by Cohen and 
Levinthal (1990). The acquisition of new knowledge can, for example, occur via the 
                                           
2Polanyi (1958) describes the state of possessing tacit knowledge as „…knowing more than we can 
tell. “ 
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hiring of additional employees, outright appropriation of other firms, joint ventures, 
or formal/informal cooperations (Kogut and Zander 1992). 
Regarding access to external knowledge, a relationship in perceptions concerning 
firms’ choice of location presents itself. According to localization theory, the 
geographical proximity between players in an innovation system strongly affects 
implicit knowledge transmission and the generation of spillovers.  Since 
biotechnology is part of a dynamic research field, new scientific insights on 
technologies and procedures are vital to a biotech firm’s survival and success. For 
this, access to talented and well trained scientists like postgraduate students and 
laboratory personnel is of particular importance. The significance of geographical 
proximity was confirmed by a series of studies (Audretsch and Feldman 1996, 
Anselin et al. 1997). Almeida and Kolgut (1999) determine that the regional 
agglomeration of knowledge (“knowledge clusters”) – access to scientific facilities 
and a correspondingly trained labor pool – can engender spillovers for firms. A 
region’s endowment of incubation facilities and highly qualified individuals is hence 
seen as an essential factor of young, innovative firms’ choice of location. Marshall’s 
fundamental view emphasizing the advantage of a so called “industrial district” 
(1890) is expanded by more recent work on the advantage of clusters (Porter 1998). 
Porter defines these as  “…a geographically proximate group of interconnected 
companies and associate intuitions in a particular field, linked by commonalities and 
complementarities”. According to Porter, positive effects on the productivity of 
firms and industries, their capacity to innovate and the development of business 
operations result from the formation of such clusters. 
Ultimately, regions equipped with biotechnology-relevant knowledge have two main 
advantages: First, such areas are more likely to be the site of firm foundations 
because of the relevant existing resources . Second, a region’s available structures 
can offer advantages to potential founders in the region and elsewhere, provided that 
said founders put down roots near these facilities. Locally situated potential founders 
in particular have access to a number of relationships with organizations in a given 
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region that could provide them with leverage in implementing their business ideas. 
The perspective shared by sociological network theory-related discourses 
(Granovetter 1973, 1985) stresses the importance of social relationships and their 
influence on economic activity. Stuart and Sorenson (2003: 250) point out that 
“sociology would appear to have ample opportunity to make a strong contribution to 
the study of high-technology entrepreneurship”. The more strongly positioned a 
group or individual is within a network (i.e., the more established its social 
relationships are), the greater its access to required resources will be. From this 
perspective, it is hardly a surprise that knowledge-intensive firms are often founded 
in immediate proximity to their founders’ work- and living environments. 
Entrepreneurs of biotechnological ventures who are embedded in these networks do 
have the chance to take advantage of having access to knowledge, financial 
institutions etc.  
The distinctiveness of regions with biotechnology-relevant knowledge is not limited 
to potential entrepreneurs who are already “embedded”. Embedded means to work 
in the region of firm location before they became entrepreneurs and having a high 
affinity to research and science. The attractiveness of available knowledge exerts a 
pull for “non-embedded founders”, meaning entrepreneurs from outside the region 
as well as entrepreneurs inside the region with low affinity to research and science. 
Related to theoretical argumentation, non-embedded people are able to increase the 
access to external knowledge when they start their firms close to research institutes 
with biotechnology relevant activities. If spillover matters, the number of non-
embedded entrepreneurs is positively influenced by the biotechnology relevant 
knowledge in the target region. From an empirical point of view, the knowledge 
variables cannot be used to test the role of spillover for “embedded” founders. For 
this group of founders, the variable measures spillover effects of research institute as 
well as founder characteristic. We are not able to distinguish both effects if and only 
if potential founder is considered in the variable. 
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Hypothesis 1: Regions with greater endowments of biotechnology-relevant 
knowledge at public and private research facilities attract more entrepreneurs.  
Hypothesis 2: Regions with greater endowments of biotechnology-relevant 
knowledge generate more spillover and attract more non-embedded entrepreneurs. 
3 Empirical Strategy 
3.1 Econometric approach 
In analogy to relevant empirical papers (see Bania et al. 1993, Harhoff 1997), we use 
a count data model to derive the partial effect of knowledge stock on the number of 
biotechnology founders from 1995 till 2003 on the level of counties. This number 
can be described with a positive numbered random variable Y following a poison or 
negative-binomial distribution. A likelihood ratio test can be applied between the 
two models. The model is parameterised in such a manner that the logarithmic 
expected value of the number of foundations is a linear function of the explanatory 
variables:  ln ( )E Y X= b  . The matrix X contains k variables by which the relevance 
of hypotheses is examined (see Table 1). The equation can be estimated via 
Maximum-Likelihood procedure.   
In addition to relevant empirical papers, we take into account the phenomenon of a 
large share of regions with zero outcomes in the number of biotechnology founders. 
This observation can be random or persistent over time. Simple count-data models 
do not differ between the two regimes, and models generate basically biased and 
inefficient estimates in the case of random observation of zero outcomes. A zero-
inflated model offers the opportunity to control for the randomness of zero outcome. 
In the fist stage, the probability for the observation of zero outcomes (regime-
equation) is estimated via Probit- or Logit-model. Subsequently, a simple count data 
model is estimated. Both stages are estimated simultaneously via Full Information 
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Maximum Likelihood estimation (see Mullahey 1986, Greene 1994). The test of 
Vuong (1989) allows to test between the simple model and the zero-inflated model.  
3.2 Identification of Biotech-Entrepreneurs 
We create an unique dataset to test our hypotheses. The starting point is the ZEW-
Foundation Panels. This panel dataset has been generated by the ZEW in 
cooperation with “Creditreform”, the largest German credit rating agency (see 
Almus et al. 2000 for further explanations). The available information includes 
among other things name and address of the firm, legal form, industry classification, 
number of employees, sales, foundation date, data regarding insolvency proceedings, 
date of last enquiry, free flow text with additional information about the firm, i.e. a 
detailed description of the firm’s business activities. Additionally, information 
regarding owner persons and managers of the firm are recorded in the database. 
However, the availability of each of the mentioned variables varies considerably. 
The identification of biotech-firms in the ZEW-Foundation Panel is based on a 
computer-assisted search for relevant strings in the description of business activity. 
The procedure is iteratively. That means, lists of firms are hand-checked and lists of 
relevant strings are updated. As a result, 874 newly founded firms between 1995 and 
2003 with activities in biotechnology-relevant fields have been identified.  
In the next step, we prepare data to biotech entrepreneurs. In this paper, an biotech 
entrepreneur is a person, who is involved with own assets in a newly founded 
biotech firm and who plays a key role for the firm’s business activities. Such a key 
role will be assumed if the person works in the senior management team of the new 
firm. In the result, our dataset contains 1,886 entrepreneurs. Data on the home region 
of entrepreneurs before they engaged in start-up activity is from ZEW-Foundation 
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Panel. We checked the plausibility of the data as we start an own inquiry.3 The 
plausibility test show very little differences.4 To sum up, Creditrefom data can be 
used for the approximation of founder’s home region.  
We are mostly interested in the effect of knowledge spillover generated by public 
research institutions to push start-ups in their region by “non-embedded” people 
who worked outside these institutions. Table 2 shows the four groups of 
entrepreneurs according the local embeddedness and affinity to research of the 
entrepreneur. All local entrepreneurs with a doctoral degree (= local scientists) form 
the group of embedded entrepreneurs. Local non-scientists and non-local founders 
(non-local scientists and non-local non-scientist) count to the group of the non-
embedded ones. The differentiation shows that 61 per cent of entrepreneurs are 
highly embedded. Scientists moving in from other regions are the second important 
group of biotech entrepreneurs.5 One fifth of all entrepreneurs are non-local 
scientists. As expected, non-scientist are less important and provide about one fifth 
of entrepreneurs.  
For the purpose of our empirical analysis, we aggregate individual information to 
the level of region.  
< insert Table 2 around here > 
3.3 Exogenous variables 
Table 3 describes our right hand side variables to explain the regional differences in 
the start-up activity of biotech entrepreneurs. Our knowledge stock variables take 
into account the heterogeneity of research activity within a region. We differentiate 
                                           
3 We collect information on the internet and start an email survey. In the result, biography data are 
available for 106 scientists which are involved in biotech start-ups. 
4 The mean distance between firms’ sitting and scientist’s home region is 71 kilometres in the 
ZEW-Foundation Panel, the median is 10 kilometres. The corresponding values in our own 
inquiry are 85 kilometres (mean) and 12 kilometres (median). 
5 The ratio of non-local scientist to all scientist reaches 25 per cent and is lower compared to the 42 
per cents of Audretsch and Stephan (1996: 647). 
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between research staff at universities and universities of applied science, research 
staff at other public research institutions and business R&D personnel.  
< insert Table 3 around here > 
In the context of regional abilities and spillover we consider, whether a region 
participated at the well-known German BioRegio-Contest (BRC).6 Participation in 
the BRC was attractive for German regions for several reasons: At first, the chance 
to receive subsidies from federal authorities. Secondly, participation also increases 
region’s prospects of being recognized by investors. Thirdly, the process of concept 
development facilitate the commercialization of already available biotechnology 
relevant knowledge in the region and accelerates its transformation into new 
products. Key players from a region’s political, scientific and economic (including 
financiers) institutions are brought together. According to sociological network 
research, this interaction is likely to produce spillovers; for example, coordinated 
measures fostering the establishment of the biotech industry, knowledge sharing and 
trust, which, among other things, foster the commercialization process. The 
attendance of the BRC leads to an exclusive possibility of having access to different 
valuable resources which could arise additional spillovers. Spillovers in BRC-
participating regions may not only result, however, from effects of participation. In 
addition, it can be assumed that only regions with a critical mass of biotechnology 
relevant knowledge and actors are able to participate in the contest. The larger the 
dimension of this ability the greater is the probability to participate at BRC. In the 
result, BRC participation variables measures effects from unobservable knowledge 
resources in the region at the time of region’s participation decision and spillovers 
                                           
6 This contest was initiated in 1995 by the Federal ministry of education and research (BMBF) and 
encouraged regions to apply for subsidies to be used in establishing a biotech industry in the 
region. The BMBF’s main goal was to stimulate the transfer of new knowledge into new 
products and thereby lessen the distance between Germany and those countries leading in the 
application of biotechnological knowledge, i.e. the US and Great Britain. Regions were invited 
to submit a development concept meant to help establish the biotech industry in their region for 
appraisal (see Dohse 2000 for details). 
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from region’s participation itself. From an empirical point of view, the variable does 
not allow a statement about the impact of BRC on start-up activity.7  
Following the discourse on the establishment of the biotech industry in Germany, 
more areas began consolidating into smaller and larger BioRegions. Spillovers 
attributable to this concerted emergence may also arise in these regions. Due to their 
varying dates of origin, however – some first appeared in 2000 – these are not 
considered in the following.  
Beside the knowledge stock variables we consider the presence of venture capital 
companies (VCC) in the region. In the line with the argument that proximity 
between VCC and the capital asking firm may it easier to acquire funding and to 
support the firm, we expect a positive coefficient estimate. Further we take into 
account effects based from start-up activity in the neighbourhood and from region’s 
endowment with sufficient and modern industrial real estates.  
 
4 Estimation results 
Table 4 shows the correlation between explanatory variables. Correlation matrix 
suggests that multicollinearity problems are of little relevance. Table 5 to Table 7 
present the estimation results of the count data model. At first, we give some notes 
to the model choice. The Likelihood-Ratio test is highly significant and emphasizes 
to reject the Poisson model. In the next step, we test on the regime of randomness of 
zero outcomes. The Vuong test statistic is almost significant and suggests the use of 
zero-inflated models in all cases.  
                                           
7 As we applied an instrumental variable (IV), we tried to emphasize the partial effect of BRC. We 
detect, however, weak instruments and thus, IV-estimates are inconsistent and must not be used 
(see Bound et al. 1995). In the result, we cannot answer the question about the partial effect of 
BRC-participation. Details are available upon author’s request. 
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At first we interpret the results for the determinants of regional differences in the 
number of all biotech entrepreneurs (Table 5). Knowledge stock at public research 
institutions contribute significantly to explain the regional differences. As expected, 
the number of biotech entrepreneurs increases with the knowledge stock. The 
knowledge stock at private research institutions do not explain the start-up activity. 
Probably, the high affinity of biotechnology research to science may explain the 
irrelevance of business R&D concentration. The result is in accordance with 
findings of Zucker et al. (1998) for the U.S.. The authors mentioned the 
insignificance of proximity to pharmaceutical industry. It is worth to note, that start-
up activity in the neighbourhood correlates positively with start-up activity in the 
region. In addition, BRC-winners as well as BRC-other participant regions achieve a 
significant higher number of entrepreneurs of newly founded biotech firms. Most 
surprisingly, we do not detect any kind of significant differences between the 
coefficient estimates BRC-winner-regions and BRC-participants (βBRC-winners=βBRC-other 
p.). Just like remember, the relevance of spillovers in BRC-participating regions and 
BRC-winner-regions is not the partial effect of BRC-participation. The positive 
coefficient only suggests that participants of BRC were more successful to attract 
biotech-entrepreneurs compared to non-participants. This can be reasoned by 
unobservable ability of participants and/or effects of participation at BRC. The 
number of local VCC-offices as well as biotech-start-up activity in previous years do 
not affect the number of biotech entrepreneurs.  
The estimation results are mostly in accordance with our expectations, in particular 
with our hypothesis 1. In the following, we focus on results for different groups of 
entrepreneurs to test our hypothesis 2 which highlights the relevance of knowledge 
spillover for different groups of entrepreneurs. A significant coefficient for 
knowledge stock variables can be interpreted as positive spillover effect to attract 
non-embedded founders. Table 6 presents the results for entrepreneurs with high 
affinity to research. The results for local scientists are very similar to the findings in 
Table 5. Again, biotechnology relevant knowledge at public research institutions 
matter. A few differences are evident for the estimation of non-local scientists. The 
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number of non-local scientists establishing a new biotech firm decreases with 
business R&D-personnel. In addition, knowledge stock at universities does not 
affect the moving in from non-local scientists. Only knowledge at non-university 
public research matter. Most interestingly, BRC-winners attract non-local scientists 
to higher extent that BRC-other participant regions. The result suggest that 
additional spillovers based on the exclusive federal support and the label of winner 
works. Also the presence of VCC matters and contributes to the explanaition of the 
moving in by non-local scientists. This findings is also supported by econometric 
analysis of Stuart and Sorenson (2003). 
We get totally different results for the start-up activity of non-scientists (Table 7). 
Neither knowledge variables nor signalling of BRC participation affect the number 
of entrepreneurs with low affinity to research. In contrast, both estimations is 
common the positive coefficient estimate for the presence of VCC. The result 
confirms the attractiveness of regions with high presence of VCC. Making the 
assumption that the variable only measures advantages of proximity between VCC 
and firm, outside entrepreneurs moving in the region in order to internalize 
spillovers from proximity. Only for the sample of non-local entrepreneurs with low 
affinity to research, we detect that regions with technology and foundation centres 
are attractive for those. To sum up, other factors may be more important for non-
scientists in comparison to scientist to moving in the region.  
Our estimation results suggest that research infrastructure attract outside scientists to 
moving in the region. We interpret the results as evidence for our hypothesis 2. 
Knowledge spillover matters and attract mobile founders from research. With 
respect to differences according the sources for knowledge spillover, universities 
provide a lower level of knowledge spillovers than other public research institutes. 
The result may suggest some inefficiencies in the knowledge transfer from 
universities to entrepreneurs of biotech firms are obvious and potentially hinder the 
commercialization of knowledge. In alternative manner, someone may argue that the 
results reflects the institutional differences with respect to the level of teaching and 
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research. Universities are more active in teaching and thus, research orientation is 
per se lower. We believe that only a deeper analysis can answer the question about 
inefficiencies. 
5 Summary  
Our study aimed at analysing the role of localized knowledge for start-up activity of 
biotech entrepreneurs. The paper is in line of work presented by Audretsch and 
Stephan (1996), Zucker et al. (1998) and Stuart and Sorenson (2003). In contrast to 
theses authors, we suggest an unique approach to test empirically on the role of 
knowledge spillovers. For these purposes, we classify entrepreneurs according their 
affinity to research and local embeddedness. The derivation of the hypotheses is 
based on the concepts of the knowledge based view as well as the economic 
geography i.e. cluster theory and theory of industrial districts.  
The descriptive findings suggest a high importance of local scientist to transfer 
scientific knowledge to the market. 61 per cent of entrepreneurs of biotech firms 
founded between 1995 till 2003 become entrepreneurs in their home region. 
Additionally 20 per cent of biotech entrepreneurs are those with high affinity to 
research who moved from outside in the region.  
As expected, the results of the multivariate analysis indicate a higher start-up 
activity of biotech entrepreneurs in knowledge intensive regions compared to other 
regions. Again, the result for all biotech entrepreneurs can be driven by knowledge 
spillovers and/or entrepreneurs’ abilities. A positive impact of knowledge spillover 
is suggested by our estimation results for different groups of entrepreneurs. We 
detect a significant positive relationship between knowledge stock at non-university 
research institutes and the number of entrepreneurs with high affinity to research and 
moving from outside in the region. We conclude that research infrastructure really 
attract outside scientists and knowledge spillover matters. In contrast to that, 
location choice of biotech entrepreneurs with low affinity to science are not affected 
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by knowledge stock in the target region. Other factors may be more important for 
these kind of entrepreneurs to explain the moving in the region.  
This conclusion is also supported by findings for efforts of regions to signalize and 
increase their competencies to establish biotechnology industry successfully. Thus, 
regions which participated in the BioRegio-contest achieve a significant higher 
number of biotech entrepreneurs with high affinity to science. Signalling matter to 
attract outside scientists. In contrast, the number of entrepreneurs with low affinity 
to science is not determined by participation state.  
Region’s knowledge stock really attract outside scientists to move in the region. 
These abilities can be pushed and signalized by the region in different ways. The 
participation at contests is one prominent example to increase the alertness of 
outside investors and entrepreneurs successfully.  
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Table 1:  Description of explanatory variables 
Variable Source Description 
Universities’ 
staff  
Statistic of destatis Number of scientists in chemistry, biology, 
medicine at universities with research 
activities in biotechnology according 
www.biotech-europe.de in 1995 (log.) 
Research. 
institutes’ staff  
Annual reports and own inquiry 
of the Max-Planck-, Helmholtz-
, Fraunhofer-, Leibniz-societies. 
Number of scientists in technical oriented 
public non-university R&D institutes with 
research activities in biotechnology 
according www.biotech-europe.de in 1996-
1998 (log.) 
Business 
R&D- 
personnel  
Stifterverband der deutschen 
Wirtschaft, NIW calculation 
and estimation for report 
„Technology Competiviness“  
R&D personnel in business in 1995 (log.) 
High-qualified  INKAR 1998 of Federal 
Agency for Construction and 
Spatial System (BBR) 
Employees with degress of 
university/university of applied science 
related to all employees in 1996  
Biotech-
startup (t-1) 
 Indicator variable with the value one if at 
least one biotech-start-ups was founded 
between 1990 and 1994 and zero otherwise 
BRC-winners Dohse (2000), own definition at 
the level of counties 
Indicatorvariable to define winner-regions 
of the BioRegio-contest 
BRC-other 
participants 
Dohse (2000), own definition at 
the level of counties 
Indicatorvariable to define other 
participants of the BioRegio-contest 
TFC Map of German Technology 
and Foundation centres 
association (ADT) 
Indicatorvariable to define counties with 
one technology- and foundations centre at 
least in 1999 
Spatial 
spillovers  
 Sum of biotech-start-ups in counties, 
located in radius of 50 kilometres around 
the county under consideration (log.) 
(=spatial lag model) 
Local VCC-
office  
Annual yearbook of German 
Private Equity association  
(BVK) 
Number of offices of venture-capital-
companies in the county in 1999 (log.)  
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Table 2:  Number of Biotech’ entrepreneurs from 1995 till 2003 according the local 
embeddedness of founders and their affinity to research 
Entrepreneur’s siting before he 
or she becomes an entrepreneur 
Entrepreneur’s highest educational level 
doctoral degree              lower than doctoral  
                                      degree 
inside the region of firm location Local scientist 
(N=1,154) 
Local non-scientist 
(N=243) 
Outside the region of firm 
location 
Non-local scientist 
(N=390) 
Non-local non-scientist 
(N=101) 
Bold letters marks the group of embedded-entrepreneurs.  
 
Table 3:  Descriptive statistics of explanatory variables 
 Mean  St.Deviation Minimum Maximum 
Universities’ staff 0.927 2.288 0.000 8.620 
Res. institutes’staff 0.416 1.363 0.000 7.054 
Busin. R&D personnel 5.123 1.606 0.000 10.280 
High-qualified  0.063 0.033 0.019 0.222 
Biotech-startup (t-1) 0.458 0.498 0 1 
BRC-winners 0.046 0.209 0 1 
BRC-other participants 0.080 0.271 0 1 
TFC 0.296 0.457 0 1 
Spatial spillover 2.352 1.243 0.000 4.673 
Local VCC-office 0.097 0.437 0.000 3.761 
 
Table 4:  Correlations between explanatory variables 
    1 2 3 4 5 6 7 8 9 
1 Universities’ staff 1.00   
2 Res. institutes’staff 0.39 1.00   
3 Busin. R&D personnel 0.36 0.25 1.00   
4 High-qualified  0.48 0.35 0.45 1.00   
5 Biotech-startup (t-1) 0.24 0.23 0.34 0.23 1.00   
6 BRC-winners 0.16 0.28 0.27 0.23 0.17 1.00   
7 BRC-other participants 0.47 0.38 0.28 0.36 0.24 -0.06 1.00  
8 TFC 0.27 0.14 0.15 0.25 0.09 0.07 0.09 1.00 
9 Spatial spillover 0.06 0.11 0.35 0.12 0.25 0.24 0.13 -0.03 1.00
10 Local VCC-office 0.47 0.33 0.36 0.39 0.21 0.22 0.34 0.07 0.15
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Table 5:  Determinants of the number of entrepreneurs of biotech firms founded 
between 1995 and 2003 
  All founders 
Explanatory variables coeff.  st-error  
Universities’ staff 0.148 *** 0.029 
Res. institutes’staff 0.159 *** 0.037 
Busin. R&D personnel -0.003   0.064 
High-qualified  0.591   2.453 
Biotech-startup (t-1) 0.064   0.180 
BRC-winners 1.132 *** 0.222 
BRC-others 0.779 *** 0.175 
TFC 0.054   0.135 
Spatial spillover 0.139 ** 0.057 
Local VCC-office 0.112   0.093 
Intercept 0.343   0.338 
alpha(ln) -0.419 
# of observations 439 
- zero outcomes 226 
βBRC-winners=βBRC-others 2.48 
Likelihood Ratio Test  
Poisson vs. NegBin 856.81 *** 
Vuong-Statistik  
zero-inflated vs. 
simple model  
3.30 *** 
*** (**) {*} significant at 1 (5) {10} percent-level of significance. Result of zero-inflated negativ-binomial-model 
with heteroscedastic robust standard errors.  
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Table 6:  Determinants of the number of scientific entrepeneurs of biotech start-ups 
founded between 1995 and 2003 
  Local non-local 
Explanatory variables coeff.  st-error  coeff.  st-error 
Universities’ staff 0.204 *** 0.044 0.062   0.044
Res. institutes’staff 0.184 *** 0.057 0.144 ** 0.058
Busin. R&D personnel 0.046   0.102 -0.331 *** 0.100
High-qualified  1.357   3.943 1.256   3.968
Biotech-startup (t-1) 0.212   0.397 -0.751 * 0.402
BRC-winners 1.037 *** 0.432 2.368 *** 0.420
BRC-others 0.654 *** 0.296 1.479 *** 0.297
TFC -0.33 * 0.268 -0.146   0.265
Spatial spillover 0.084   0.100 -0.011   0.092
Local VCC-office -0.068   0.119 1.479 *** 0.297
Intercept -0.28   0.546 -0.146   0.265
alpha(ln) -0.275 0.114
# of observations 439   439   
- zero outcomes 298 337
βBRC-winners=βBRC-other p. 2.09  5.21 ** 
Likelihood Ratio Test  
Poisson vs. NegBin 573.78 *** 275.40 *** 
Vuong-Statistik  
zero-inflated vs. 
simple model  
3.02 *** 4.53 *** 
*** (**) {*} significant at 1 (5) {10} percent-level of significance. Result of zero-inflated negativ-binomial-model 
with heteroscedastic robust standard errors.  
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Table 7:  Determinants of the the number of non-scientific entrepeneurs of biotech start-
ups founded between 1995 and 2003 
  Local non-local  
Explanatory variables coeff.  st-error  coeff.  st-error 
Universities’ staff 0.006   0.038 0.023   0.035
Res. institutes’staff 0.026   0.056 0.050   0.046
Busin. R&D personnel -0.075   0.082 0.009   0.069
High-qualified  3.727   3.494 3.247   3.071
Biotech-startup (t-1) 0.154   0.291 -0.057   0.207
BRC-winners 0.016   0.510 -0.003   0.444
BRC-others 0.242   0.395 0.371   0.280
TFC 0.506   0.312 0.380 ** 0.167
Spatial spillover 0.104   0.084 0.137 * 0.074
Local VCC-office 0.480 *** 0.119 0.330 *** 0.102
Intercept -0.504   0.628 -0.608   0.491
alpha(ln) -1.529 0.151
# of observations 439   439   
- zero outcomes 324 304
βBRC-winners=βBRC-other p. 0.55  2.89 * 
Likelihood Ratio Test  
Poisson vs. NegBin 53.09 *** 3.30 ** 
Vuong-Statistik  
zero-inflated vs. 
simple model  
2.47 *** 2.68 *** 
*** (**) {*} significant at 1 (5) {10} percent-level of significance. Result of zero-inflated negativ-binomial-model 
with heteroscedastic robust standard errors.  
 
